Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Advertisement The FDA first announced two months ago that ... new government data shows. Sleep apnea is known to wreak havoc on the body and also appears to have direct effects on brain health ...

The FDA's heightened warning comes after reviewing ... and Drug Administration for treating moderate to severe obstructive sleep apnea. Health News // 8 hours ago Missouri judge partially blocks ...

Nyxoah SA (NASDAQ:NYXH), a medical technology company specializing in the treatment of obstructive sleep apnea (OSA), has been ... focus for Nyxoah is obtaining FDA approval for the Genio system ...

Spring-based Texas Sinus & Snoring (346-413-9313) announces an innovative new treatment for obstructive sleep apnea, eliminating the need for the ... With the recent announcement, the center offers ...

Obstructive sleep apnea sufferers in Spring, The Woodlands, and Houston now have access to an FDA-approved new treatment from Texas Sinus and Snoring. Known as Inspire, the implantable device uses ...